Variant peptides with N- or C-terminal truncations and/or alanine substitutions were tested for their ability to block binding to the parent 20-mer peptides in an ELISA. In case the peptide in question contained an alanine, the alanine was replaced by a serine instead. Ninety-six-well plates were coated with 100 μl NeutrAvidin per well at a concentration of 0.5 μg/ml. The plates were incubated overnight at 4°C and washed 4 times with PBS plus 0.05% Tween 20. One hundred microliters of blocking buffer (PBS plus 10% FBS) was added to the plates, and the plates were incubated for 90 min at 4°C. Subsequently, the blocking buffer was discarded, 100 μl of biotinylated 20-mer peptide at 200 ng/ml was added to the plate, and the plates were incubated for 90 min at 4°C. Selected antibodies were simultaneously incubated with variant peptides. We used 30 μl/well of MAb at 600 ng/ml and incubated it with 30 μl/well of alanine-modified peptides at 100 μg/ml for 90 min at 4°C. After the plates were washed, 50 μl of the antibody-alanine peptide mix was added to the plate-bound peptides and the plates were incubated for 20 min at 4°C. The plates were washed, 100 μl/well of secondary goat anti-mouse IgGγ conjugated to HRP (diluted 1:1,000 in blocking buffer) was added, and the plates were incubated for 90 min at 4°C. A final wash step was performed, the plates were developed using o-phenylenediamine, and the OD490 was read on a SpectraMax 250 spectrophotometer (Molecular Devices).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.